House Ways and Means Committee Takes Important Step to Further Medical Innovation
Neurosurgeons Applaud the Committee for Approving Legislation to Repeal the Medical Device Tax
Washington, DC – The American Association of Neurological Surgeons (AANS) and Congress of
Neurological Surgeons (CNS) commend the U.S. House Ways and Means Committee for passing out of
committee, H.R. 160, the “Protect Medical Innovation Act.” This bipartisan bill has over 280 cosponsors
and would repeal the medical device tax.
Created by the Affordable Care Act, the medical device tax is a 2.3 percent excise tax that applies to the
gross sales of medical device products. This tax imposes over $30 billion in new taxes and is adversely
affecting medical innovation and patient care.
AANS president, H. Hunt Batjer, MD, noted, “Repealing the medical device tax is among neurosurgery’s
top legislative priorities and we applaud the bipartisan efforts of Congress to abolish this arbitrary tax,
which is ill-advised and ultimately will negatively impact our patients.”
According to a recent study published by the Advanced Medical Technology Association (AdvaMed), as
many as 195,000 jobs may be lost due to the tax, either through layoffs or forgone jobs that would have
been created.
“Our healthcare system needs innovation to improve patient care and save lives. Instead, this tax stifles
innovation and reduces patient access to new lifesaving technologies,” said CNS president, Nathan R.
Selden, MD.
The AANS and CNS have endorsed both H.R. 160 and S. 149, the “Medical Device Access and
Innovation Protection Act,” and look forward to working with Congress to develop policy solutions that
better support medical innovation and increase treatment options for our patients.
Read full article here
